Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.11 | 0.7 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |